CAS: 1206163-45-2
GLPG-0778
CAS:1206163-45-2
Formula:
C22H23N5O2
Purity:
98+%
Color and Shape:
Solid
Molecular weight:
389.4503
Ref: AN-AG008TN5
| 5mg | 64.00 € | |
| 10mg | 86.00 € | |
| 50mg | 165.00 € | |
| 100mg | 278.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
Solcitinib
CAS:1206163-45-2
Solcitinib (GLPG-0778) (GSK2586184, GLPG0778) is a JAK1 inhibitor. Solcitinib may be potentially used for the …
Formula:
C22H23N5O2
Purity:
99.82%
Color and Shape:
Solid
Molecular weight:
389.45
Ref: TM-T3620
| 1mg | 37.00 € | |
| 2mg | 52.00 € | |
| 5mg | 78.00 € | |
| 10mg | 94.00 € | |
| 25mg | 147.00 € | |
| 50mg | 185.00 € | |
| 100mg | 305.00 € | |
| 200mg | 494.00 € | |
| 1ml*10 (DMSO) | 85.00 € |
Estimated delivery in United States, on Wednesday 15 May 2024
![N-(5-(4-(3,3-Dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide](https://static.cymitquimica.com/products/10/thumb/F497231.jpg)
N-(5-(4-(3,3-Dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
CAS:1206163-45-2
Purity:
95.0%
Molecular weight:
389.4590148925781
Ref: 10-F497231
| 1g | To inquire | |
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
Solcitinib
CAS:1206163-45-2
Solcitinib is a Jak1 inhibitor that is being evaluated for its potential to treat cancer. …
Formula:
C22H23N5O2
Purity:
Min. 95%
Molecular weight:
389.45 g/mol
Ref: 3D-GYB16345
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024
